Clinical trialNCT07021066RecruitingPhase 1Interventional

Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors

SponsorSystImmune Inc.Enrollment160Advanced Pancreatic Ductal AdenocarcinomaBiliary Tract CancerEsophageal AdenocarcinomaGastric AdenocarcinomaOther Solid Tumors

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Sarah Tannenbaum
SystImmune Inc.
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Mayo Clinic Cancer Center- Phoenix
Phoenix, Arizona, United States
Tainos Bekaii-Saab
Recruiting
Honorhealth
Scottsdale, Arizona, United States
Sunil Sharma
Recruiting
University of Colorado Health
Aurora, Colorado, United States
Sunnie Kim
Recruiting
Yale Cancer Center
New Haven, Connecticut, United States
Michael Cecchini
Recruiting
Ochsner Medical Center
New Orleans, Louisiana, United States
Jonathan Mizrahi
Recruiting
University of Michigan
Ann Arbor, Michigan, United States
Vaibhav Sahai
Recruiting
Karmanos Cancer Institute
Detroit, Michigan, United States
Wasif Saif
Recruiting
Hackensack University Medical Center
Hackensack, New Jersey, United States
Martin Guiterrez, MD
Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Michael May
Not, yet, recruiting
Sarah Cannon Research Institute - Oncology Partners
Nashville, Tennessee, United States
Meredith Pelster
Recruiting
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
Dana Cardin
Not, yet, recruiting
Next Oncology- Austin
Austin, Texas, United States
Sheena Sahota
Recruiting
Next Oncology- Dallas
Dallas, Texas, United States
Michael Song
Recruiting
Md Anderson
Houston, Texas, United States
Jaffer Ajani
Not, yet, recruiting
Next Oncology San Antonio
San Antonio, Texas, United States
David Sommerhalder
Recruiting
Start Center for Care Center- San Antonio
San Antonio, Texas, United States
Drew Rasco
Not, yet, recruiting
Baylor Scott and White Medical Center- Temple Clinic
Temple, Texas, United States
Lucas Wong
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

BL-M05D1

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jul 2025
Primary completion: 28 Feb 2027
Completion: 31 May 2027
Last update posted: 30 Apr 2026
Registered enrollment: 160
Registry id: NCT07021066

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.